Asthma and COPD Associated With Increased Pertussis Risk
Patients aged 10 years and older with asthma or chronic obstructive pulmonary disease (COPD) have a greater pertussis risk and an increased […]
Clinical Testing Guidance from CDC
Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients with Community-Acquired Pneumonia A number of the diseases that the Mycotic Diseases […]
First Annual APAPP National Conference
The Association of Pulmonary Advanced Practice Providers (APAPP) is the first association to focus solely on advanced practice providers (APPs) working in […]
How Sleep Medicine Fits in ACO’s
Fariha Abbasi-Feinberg, MD, FAASM, member of AASM Board of Directors, has had a 25-year career in sleep medicine and has many insights […]
ATS Clinical Practice Guideline Addresses SSc-ILD Treatment
The Association of Pulmonary Advanced Practice Providers (APAPP) is excited to highlight the American Thoracic Society’s evidence-based clinical practice guideline for the […]
Antithrombotic Therapy in COVID-19- Guidelines from CHEST
As a Pulmonary APP, you live the complexities of post-COVID-19 with your patients daily. That is why APAPP wants to share the […]
PH Awareness Month
As many APAPP Members already know, November is Pulmonary Hypertension Awareness Month. The Pulmonary Hypertension Association (PHA) has deemed this year’s theme […]
Meet The Bronch Queen: A Nurse Practitioner’s Story
Over the last several years, the role of the Advanced Practice Provider (APP) in the ICU has been evolving. As intensivist models have developed across the country, it has become apparent for the need for continuous provider coverage in the ICU and APPs have filled this gap.
Complexity of the Evaluation and Diagnosis of Pulmonary Hypertension
Pulmonary hypertension is a rare condition, and even rarer is pulmonary arterial hypertension.